Karnataka High Court Allows ‘The Liver Doc’ To Access X Account

Mumbai: The Karnataka High Court on Tuesday modified a trial court order to suspend the account of hepatologist Cyriac Abby Philips – known as “The Liver Doc” – on microblogging platform X, reported Bar and Bench.

Justice SG Pandit allowed him to access his account after Philips gave an undertaking that he would temporarily take down allegedly defamatory posts against pharmaceutical company Himalaya Wellness till the case is pending in the courts.

The court issued a notice to X, formerly known as Twitter.

The social media company withheld Philip’s account on September 28 after Additional City Civil and Session Judge DP Kumaraswamy passed an ex-parte order directing the removal of his posts. An ex-parte order is one that is passed without all the parties to a litigation being present before the judge.

In a defamation suit against Phillips, Himalaya Wellness accused him of posting false derogatory statements about its products in order to promote the products of rival companies Cipla and Alchem.

At the hearing, Kumaraswamy had said that there was a need to issue an injunction against Phillips to minimise the damage caused to the company, including loss of reputation and money.

The court added that the doctor’s statements were doing a disservice to consumers who benefit from Himalaya products such as Liv-52.

On October 6, Phillipps moved the High Court, challenging Kumaraswamy’s orders.

Appearing for him, senior counsel Aditya Sondhi submitted that this “disproportionate, draconian order could not have been passed by the trial court”.

Upon the court’s question about what modifications are being sought to the order, Sondhi asked for the X account to be restored. “The nine offending tweets may be hidden,” he said.

The counsel, however, clarified that he was not conceding that the tweets were defamatory since Himalaya’s product in question was banned in the US.

The matter will be heard again in the second week of November.

Related Posts

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

The Central Drugs Standard Control Organisation (CDSCO) found one spurious and 220 not of standard quality (NSQ) drug samples from a batch tested randomly as part of the August drug…

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

The action follows the department’s investigation into a large-scale unlicenced drug repacking and relabelling racket uncovered at a farmhouse in Bengaluru South district’s Bidadi on August 18. The Karnataka Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

CDSCO finds one spurious drug sample in Delhi, 220 NSQs in Aug surveillance

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

FSDA cancels 16 pharmacy licences, suspends 8, including Pfizer depot

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

WHO launches new primary health care course to strengthen health systems globally

WHO launches new primary health care course to strengthen health systems globally

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman